These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4406001)

  • 21. Visual evoked potentials in Basedow's ophthalmopathy before and after orbital decompression or retrobulbar irradiation.
    Setälä K; Raitta C; Välimäki M; Katevuo K; Lamberg BA
    Exp Clin Endocrinol; 1991 May; 97(2-3):344-7. PubMed ID: 1915654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience of radiation therapy for Graves' ophthalmopathy.
    Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
    Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM; Liu W; Lu GH
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Orbital radiation in Graves' disease.
    Rubenzik R
    Am J Ophthalmol; 1975 May; 79(5):888-9. PubMed ID: 1173740
    [No Abstract]   [Full Text] [Related]  

  • 25. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk factors in Graves's-Basedow's disease].
    Radosavljević V; Janković S
    Srp Arh Celok Lek; 1995; 123(7-8):215-7. PubMed ID: 17974432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Treatment of Graves's disease after 131 I.
    Hamburger JI
    N Engl J Med; 1975 May; 292(18):977. PubMed ID: 1172997
    [No Abstract]   [Full Text] [Related]  

  • 28. Graves' disease of the orbit.
    Weber AL; Dallow RL; Sabates NR
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of Graves' ophthalmopathy with irradiation].
    Slampa P; Spurný V; Seneklová Z; Krákorová D
    Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
    Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased post-heparin lipases in Graves's disease.
    Arons DL; Schreibman PH; Downs P; Braverman LE; Arky RA
    N Engl J Med; 1972 Feb; 286(5):233-7. PubMed ID: 5066600
    [No Abstract]   [Full Text] [Related]  

  • 33. Squamous cell carcinoma of the eyelid masquerading as 'malignant' ophthalmopathy of Graves's disease.
    Ford HC; Delahunt JW; Teague CA
    Br J Ophthalmol; 1983 Sep; 67(9):596-9. PubMed ID: 6688354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary cyclic AMP in Graves's disease.
    Rosen OM
    N Engl J Med; 1972 Sep; 287(13):670-1. PubMed ID: 4342525
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: Rosette inhibition in Graves's disease.
    Chapel HM; Batchelor JR
    N Engl J Med; 1974 Jul; 291(2):103. PubMed ID: 4406909
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy.
    Philip R; Saran S; Gutch M; Agroyia P; Tyagi R; Gupta K
    Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S157-9. PubMed ID: 24251142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmic Graves's disease.
    Br Med J; 1967 May; 2(5548):329-30. PubMed ID: 6071508
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperophthalmopathic Graves's disease; clinical observations in nineteen cases.
    HEDGES TR; ROSE E
    AMA Arch Ophthalmol; 1953 Oct; 50(4):479-90. PubMed ID: 13091524
    [No Abstract]   [Full Text] [Related]  

  • 39. Graves's disease: the clinical types and their management.
    RUNDLE FF
    Br Med J; 1951 Dec; 2(4745):1433-6. PubMed ID: 14879124
    [No Abstract]   [Full Text] [Related]  

  • 40. Clues to the aetiology of Graves's disease.
    MEANS JH
    Lancet; 1949 Sep; 2(6578):543-8. PubMed ID: 18140704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.